COMPARISON OF OUTCOMES AFTER DONOR LYMPHOCYTE INFUSION WITH OR WITHOUT PRIOR CHEMOTHERAPY FOR MINIMAL RESIDUAL DISEASE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

被引：0

作者：

Mo, X. -D. ^{[1
]}

Zhang, X. -H. ^{[1
]}

Xu, L. -P. ^{[1
]}

Wang, Y. ^{[1
]}

Yan, C. -H. ^{[1
]}

Chen, H. ^{[1
]}

Chen, Y. -H. ^{[1
]}

Han, W. ^{[1
]}

Wang, F. -R. ^{[1
]}

Wang, J. -Z. ^{[1
]}

Liu, K. -Y. ^{[1
]}

Huang, X. -J. ^{[1
]}

机构：

[1] Peking Univ, Peoples Hosp, Inst Hematol, Beijing, Peoples R China

来源：

HAEMATOLOGICA | 2017年 / 102卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

E1515

引用

页码：618 / 618

页数：1

共 50 条

[41] Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation [J].

Tsirigotis, P. ;

Danylesko, I. ;

Gkirkas, K. ;

Shem-Tov, N. ;

Yerushalmi, R. ;

Stamouli, M. ;

Avigdor, A. ;

Spyridonidis, A. ;

Gauthier, J. ;

Goldstein, G. ;

Apostolidis, J. ;

Mohty, M. ;

Shimoni, A. ;

Nagler, A. .

BONE MARROW TRANSPLANTATION, 2016, 51 (10) :1313-1317

[42] Significance of Minimal Residual Disease in Patients with Chronic Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation [J].

Solarska, Iwona ;

Nasilowska-Adamska, Barbara ;

Bieniaszewska, Maria ;

Zaucha, Jan Maciej ;

Rzepecki, Piotr ;

Sawicki, Waldemar ;

Calbecka, Malgorzata ;

Lech-Maranda, Ewa ;

Marianska, Bozena ;

Warzocha, Krzysztof .

BLOOD, 2009, 114 (22) :1266-1266

[43] Minimal residual disease markers before and after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia [J].

Dominietto, Alida .

CURRENT OPINION IN HEMATOLOGY, 2011, 18 (06) :381-387

[44] Minimal residual disease monitoring and preemptive immunotherapy in myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation [J].

Xiao-Dong Mo ;

Ya-Zhen Qin ;

Xiao-Hui Zhang ;

Lan-Ping Xu ;

Yu Wang ;

Chen-Hua Yan ;

Huan Chen ;

Yu-Hong Chen ;

Wei Han ;

Feng-Rong Wang ;

Jing-Zhi Wang ;

Kai-Yan Liu ;

Xiao-Jun Huang .

Annals of Hematology, 2016, 95 :1233-1240

[45] Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation [J].

P Tsirigotis ;

I Danylesko ;

K Gkirkas ;

N Shem-Tov ;

R Yerushalmi ;

M Stamouli ;

A Avigdor ;

A Spyridonidis ;

J Gauthier ;

G Goldstein ;

J Apostolidis ;

M Mohty ;

A Shimoni ;

A Nagler .

Bone Marrow Transplantation, 2016, 51 :1313-1317

[46] DONOR LYMPHOCYTE INFUSION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN CHILDREN: SINGLE CENTER EXPERIENCE [J].

Park, J. E. ;

Lee, K. C. ;

Jung, H. J. ;

Lee, S. W. .

BONE MARROW TRANSPLANTATION, 2014, 49 :S494-S494

[47] MINIMAL RESIDUAL DISEASE MONITORING AND PREEMPTIVE IMMUNOTHERAPY IN MYELODYSPLASTIC SYNDROME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION [J].

Mo, X. D. ;

Qin, Y. Z. ;

Zhang, X. H. ;

Xu, L. P. ;

Wang, Y. ;

Yan, C. H. ;

Chen, H. ;

Chen, Y. H. ;

Han, W. ;

Wang, F. R. ;

Wang, J. Z. ;

Liu, K. Y. ;

Huang, X. J. .

HAEMATOLOGICA, 2016, 101 :501-501

[48] Minimal residual disease monitoring and preemptive immunotherapy in myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation [J].

Mo, Xiao-Dong ;

Qin, Ya-Zhen ;

Zhang, Xiao-Hui ;

Xu, Lan-Ping ;

Wang, Yu ;

Yan, Chen-Hua ;

Chen, Huan ;

Chen, Yu-Hong ;

Han, Wei ;

Wang, Feng-Rong ;

Wang, Jing-Zhi ;

Liu, Kai-Yan ;

Huang, Xiao-Jun .

ANNALS OF HEMATOLOGY, 2016, 95 (08) :1233-1240

[49] Adoptive immunotherapy with donor lymphocyte infusion after allogeneic nonmyeloablative stem cell transplantation. [J].

Qiao, ZH ;

Zheng, ZZ ;

Ye, F ;

Ma, LM ;

Gong, R .

BLOOD, 2005, 106 (11) :383B-383B

[50] Donor lymphocyte infusions for the treatment of relapse after allogeneic hematopoietic stem cell transplantation. [J].

Riera, L ;

Koziner, B .

MEDICINA-BUENOS AIRES, 2000, 60 (02) :259-269

← 1 2 3 4 5 →